Business Standard

IPCA Labs stock hits valuation hurdle on Unichem stake acquisition

Improving growth and expanding margins in competitive US market will be key challenges

Ipca
Premium

Ipca

Ram Prasad Sahu Mumbai

Listen to This Article

The IPCA Laboratories stock fell 10.22 per cent on Tuesday and hit a 52-week low as the Street reacted negatively to its 33 per cent stake acquisition in Unichem Laboratories (Unichem) for Rs 1,034 crore. The acquisition from one of Unichem’s promoters at Rs 440 per share – a 14 per cent premium to Monday’s closing price – will be followed by an open offer for an additional 26 per cent.

The company will fund the equity purchase and open offer (Rs 800 crore) through internal accruals. The deal – including the open offer when fully subscribed – will take

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 25 2023 | 1:15 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com